117 related articles for article (PubMed ID: 3891197)
1. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.
Roth RA
Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197
[TBL] [Abstract][Full Text] [Related]
2. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
Wiersma DA; Roth RA
Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365
[TBL] [Abstract][Full Text] [Related]
3. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
Wiersma DA; Roth RA
J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
[TBL] [Abstract][Full Text] [Related]
4. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
Wiersma DA; Roth RA
J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
[TBL] [Abstract][Full Text] [Related]
5. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance.
Wiersma DA; Roth RA
J Pharmacol Exp Ther; 1980 Jan; 212(1):97-102. PubMed ID: 7351629
[TBL] [Abstract][Full Text] [Related]
6. Effect of intratracheally instilled benzo(a)pyrene on the pulmonary and hepatic drug-metabolizing enzymes in normal and vitamin A deficient rats.
Dogra SC; Khanduja KL; Sharma RR
Biochem Int; 1985 Mar; 10(3):373-83. PubMed ID: 4015664
[TBL] [Abstract][Full Text] [Related]
7. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon.
Mukhtar H; Del Tito BJ; Das M; Cherniack EP; Cherniack AD; Bickers DR
Cancer Res; 1984 Oct; 44(10):4233-40. PubMed ID: 6088034
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat.
Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U
Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530
[TBL] [Abstract][Full Text] [Related]
9. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.
Foth H; Mollière M; Kahl R; Jähnchen E; Kahl GF
Drug Metab Dispos; 1984; 12(6):760-6. PubMed ID: 6150827
[TBL] [Abstract][Full Text] [Related]
10. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
Atal CK; Dubey RK; Singh J
J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pulmonary benzo(a)pyrene 4,5-oxide clearance: a pharmacokinetic analysis of epoxide-metabolizing enzymes in rabbit lung.
Smith BR; Bend JR
J Pharmacol Exp Ther; 1980 Sep; 214(3):478-82. PubMed ID: 7190605
[TBL] [Abstract][Full Text] [Related]
12. Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition.
Roth RA; Vinegar A
Pharmacol Ther; 1990; 48(2):143-55. PubMed ID: 2293237
[TBL] [Abstract][Full Text] [Related]
13. Benzo(a)pyrene metabolism in hepatic microsomes from feral and 3-methycholanthrene-treated southern flounder, Paralichthys lethostigma.
Little PJ; James MO; Pritchard JB; Bend JR
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):309-20. PubMed ID: 6520733
[TBL] [Abstract][Full Text] [Related]
14. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
15. The influence of some disease states on drug disposition.
Wilson K; Bromberg T
Methods Find Exp Clin Pharmacol; 1981; 3(3):189-200. PubMed ID: 7253775
[TBL] [Abstract][Full Text] [Related]
16. The development of models for the evaluation of pulmonary drug disposition.
Liu X; Jin L; Upham JW; Roberts MS
Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
[TBL] [Abstract][Full Text] [Related]
17. Age-related changes in benzo(a)pyrene metabolism and epoxide-metabolizing enzyme activities in rat skin.
Mukhtar H; Bickers DR
Drug Metab Dispos; 1983; 11(6):562-7. PubMed ID: 6140140
[TBL] [Abstract][Full Text] [Related]
18. Effects of liver congestion on hepatic drug metabolism in the rat.
Knodell RG; Farleigh RM; Steele NM; Bond JH
J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
[TBL] [Abstract][Full Text] [Related]
19. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
[TBL] [Abstract][Full Text] [Related]
20. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
Shibata Y; Takahashi H; Ishii Y
Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
